Patenting of CRISPR Gene Editing Technology: A Case of Monopoly or Innovation

Lagta hai, do saal pehle abhi CRISPR gene editing technology ke patent ko lekar koi controversy thi. Lekin ab isko lekar news aayi, jo mere liye kafi ruchi hai. Naukri.com ke owner, Info Edge, ne US ke patent office se CRISPR gene editing technology ke patent ko cancel karwana seekha hai. Unka khayal hai ki patent ke madhyam se US ne India ki start-ups ko rok diya hai. Is case mein, Section 3(d) of Patents Act, 1970 ka use kiya ja raha hai, jo patented invention ke madhyam se public ko faayda karne ke liye aavashyak hai.